Amphotericin B is an effective but toxic antileishmanial agent. Lipid-encapsulated amphotericin B should have a high therapeutic index for visceral leishmaniasis because reticuloendothelial cells, the sole site in which Leishmania is found, will phagocytize and concentrate the complex. Amphotericin B cholesterol dispersion (Amphocil; 2 mg/[kg.d] intravenously) was administered to 10 Brazilians with kala-azar for 10 days (cohort 1) and to 10 Brazilians with kala-azar for 7 days (cohort 2). All patients were successfully treated: 19 of the 20 patients were without visible parasites in the bone marrow; the mean time to afebrility was 4.2 days; spleen size regressed by a mean of 79% 2 months after therapy; and no patient had clinical or laboratory abnormalities by the end of 6-12 months of follow-up. Side effects were fever and chills accompanied by respiratory distress, but not nephrotoxicity, in children < 3 years of age.
We have treated 10 patients suffering from kala-azar in Brazil with Amphocil (amphotericin B cholesterol dispersion) at a dose of 2 mg/kg/d for 5 d, following an earlier study in which this dosage for 7 d was found to cure all of 9 patients, with no relapse during 12 months. In the present study, all patients demonstrated initial resolution of disease. Parasites were absent upon bone marrow re-aspiration 2 weeks after therapy; no spleen extended beyond the costal margin 2 months after therapy; white blood cell counts, platelet counts, and serum levels of albumin rapidly returned to normal. Although one patient relapsed at 5 months, 8 of the other 9 patients had spleens of normal size (undetectable on deep palpation) at 12 months after therapy. Fever, sometimes accompanied by increased respiratory rate, occurred on the first day of drug infusion in 8 of 10 patients and was more severe in patients < 6 years old. Pre-medication with a non-steroidal anti-inflammatory agent (diclofenac potassium) before the next 4 infusions protected against this side effect in 5 of 6 patients. The results of this and our previous study suggest that the most appropriate regimen of Amphocil for kala-azar is 2 mg/kg/d for 7 d, with pre-medication each day, in patients aged > 5 years.
The aim of this study was to test a pellet formulation in a sodium alginate matrix of Duddingtonia flagrans in the biological control of goat gastrointestinal helminths kept in a native pasture in a semi-arid region of Paraíba state, northeastern Brazil. An area of 2.4 ha was divided into three paddocks, where groups of seven goats ware formed. Each group received the following treatments during the months of March to August 2011: D. flagrans group, received 3g of pellets containing D. flagrans (AC001) for each 10 kg/l.w., twice a week; Moxidectin 0.2% group, received 0.2mg/kg of Moxidectin 0.2% orally, every 30 days; Control group, received 3g of pellets without fungi per 10 kg/l.w., twice a week. Each month, a tracer goat was placed in each group for 30 days and then sacrificed and necropsied. The D. flagrans group showed a greater reduction in EPG, increased weight gain, higher rates of packed cell volume and lower parasitic load burden in the tracer goats compared to Moxidectin 0.2% and Control groups. D. flagrans was efficient in controlling goat gastrointestinal helminthiasis in a semi-arid region of northeastern Brazil.
This study aimed to evaluate the utilization of FAMACHA(©) method as an auxiliary strategy to use the individual identification for the selective control of gastrointestinal helminthiasis in naturally infected dairy goats. The experiment was conducted on 63 farms in the towns of Passagem, Quixabá and Cacimba de Areia, semiarid region of the Paraíba state, Brazil. Fifty animals were used on each farm, being visited tree farms per month, totaling 1800 animals, between May 2009 and April 2010. The animals received no anthelmintic treatment for at least four months prior to the farm visits. All animals were subjected to parasitological faecal collection, blood sampling for packed cell volume and the visual/selective exam of the eye colour through the FAMACHA(©) method. Larvae culture was performed in every assessment on each farm. Haemonchus sp. was the most prevalent helminth (80.1%) on larval cultures. The use of this method allowed a reduction of 79.2% on anthelmintic application in dairy goats. The FAMACHA(©) method proved to be a viable auxiliary strategy to control gastrointestinal helminthiasis of dairy goats from a resource-poor area in the semiarid region of the Paraíba state, Northeastern Brazil.
Gastrointestinal helminthiasis represents an obstacle to goat raising, causing severe damage to herds such as growth retardation, weight loss, and even death. In this study, we aimed to determine the prevalence and risk factors associated to goat gastrointestinal helminthiasis in the Sertão region of Paraíba State, Brazil. A total of 256 goats from 54 farms were systematically sampled. Blood and fecal samples were collected from each animal for egg per gram (EPG), larval culture, and packed cell volume (PCV) analyses. We found that 79.3% of the goats investigated were parasitized with gastrointestinal helminths. Significant correlation (p = 0.004) was observed between the EPG and PCV of the animals studied, and it was observed that the EPG increases as the PCV decreases. In the larval culture, the most prevalent helminth was Haemonchus sp. (83.2%). Age and sex were significant variables (p ≤ 0.20) for the development of gastrointestinal helminths: 86.8% of animals over 36 months of age and 81.7% of females were infected. The variable type of animal exploitation was also significant, with 90.3% (p ≤ 0.20) of the animals presenting double suitability (milk and meat). The Sertão region of Paraíba State presents high prevalence of gastrointestinal helminthiasis in goats, and age and type of animal exploitation are the most relevant risk factors to the development of these parasites.
This study aimed to evaluate coadministration of Duddingtonia flagrans and Monacrosporium thaumasium in a sodium alginate matrix for controlling gastrointestinal helminths in young and adult sheep in the semiarid region of northeastern Brazil. An area of 1ha was divided into two paddocks, in which two experimental groups (fungus and control) were formed, each consisting of six adult females and ten young males. In each group, two subgroups were formed in accordance with the animal category (adult or young). In the fungus group, each animal received 3g of pellets containing 0.6g of fungal mycelium, with 0.3g of D. flagrans and 0.3g of M. thaumasium for each 10 kg of body weight, in their feed twice a week, for six months. In the control group, each animal received 3g of pellets without fungus for each 10 kg of body weight, in their feed twice a week, for six months, serving as a witness group. Reductions in numbers of eggs per gram of feces of 76% among the adult sheep in the fungus group and 83% among the young sheep in the fungus group were observed, in comparison with their respective control subgroups. The groups that received these fungi needed less salvage deworming and presented better packed cell volume percentages, better weight gain and lower levels of L3/kg dry matter in their paddock than the control groups. Thus, it was concluded that coadministration of D. flagrans and M. thaumasium was effective in controlling gastrointestinal helminths of adults and young sheep in the semiarid region of northeastern Brazil.
In this study, we investigated the presence of gastrointestinal helminths in 97 captive birds (Psittaciformes and Accipitriformes) necropsied between June and December 2011 in the state of Paraiba, Brazil. Forty-three birds were infected. Psittaciformes were infected by nematode Ascaridia hermaphrodita (97.6%) and cestode Raillietina sp. (2.4%). A. hermaphrodita was found in all species of parrots and Raillietina sp. was found only in Amazona aestiva. A. hermaphrodita was the cause of death, by intestinal obstruction, in 14 of the 40 birds investigated. Accipitriformes were infected by nematode Synhimantus (Synhimantus) rectus (100%) and acantocephalan Centrorhynchus tumidulus (50%). In Brazil, Diopsittaca nobilis and A. aestiva are reported for the first time as hosts of A. hermaphrodita and Raillietina sp., respectively. We concluded that Psittaciformes and Accipitriformes in captivity are affected by nematodes, cestodes and acanthocephalans and that implementation of control measures is essential.Keywords: Acanthocephalans, accipitriformes, cestodes, nematodes, psittaciformes. ResumoEste estudo objetivou-se investigar a presença de parasitos gastrointestinais em aves de cativeiro da Ordem Psittaciformes e Accipitriformes no estado da Paraíba-Brasil. Foram necropsiadas 97 aves durante o período de junho a dezembro de 2011. Em 43 (44.3%) aves, foi detectada a presença de nematóides, cestóides e/ou acantocéfalos. A prevalência de parasitos gastrointestinais em Psittaciformes foi de 45.6% (41/88) e os helmintos identificados foram Ascaridia hermaphrodita (Ascaridoidea, Ascarididae) (40/41, 97.6%) e Raillietina sp. (Cyclophyllidea, Davaineidae) (1/41, 2.4%). A. hermaphrodita foi encontrada em todas as espécies de papagaios e Raillietina sp. foi encontrada apenas na Amazona aestiva. Em aves Accipitriformes, a prevalência foi de 22.2% (2/9) e os helmintos identificados foram Synhimantus (Synhimantus) rectus (Spirurida, Acuariidae) (2/2, 100%) e Centrorhynchus tumidulus (Acanthocephala, Centrorhynchidae) (1/2, 50 %). Todos os parasitos encontrados neste estudo são relatados pela primeira vez em aves Psittaciformes e Accipitriformes no estado da Paraíba. No Brasil, Diopsittaca nobilis e A. aestiva são apresentados pela primeira vez como hospedeiros da A. hermaphrodita e Raillietina sp., respectivamente. Concluiu-se que aves Psittaciformes e Accipitriformes de cativeiro são afetadas por nematóides, cestóides e acantocéfalos, e que a implementação de medidas de controle é imprescindível.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
334 Leonard St
Brooklyn, NY 11211
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.